- Home
- RPRX vs JOBY Comparison
RPRX vs JOBY Comparison
Compare RPRX & JOBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- JOBY
- Stock Information
- Founded
- RPRX 1996
- JOBY 2009
- Country
- RPRX United States
- JOBY United States
- Employees
- RPRX N/A
- JOBY N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- JOBY Aerospace
- Sector
- RPRX Health Care
- JOBY Consumer Discretionary
- Exchange
- RPRX Nasdaq
- JOBY Nasdaq
- Market Cap
- RPRX 15.6B
- JOBY 14.3B
- IPO Year
- RPRX 2020
- JOBY N/A
- Fundamental
- Price
- RPRX $36.03
- JOBY $18.96
- Analyst Decision
- RPRX Strong Buy
- JOBY Buy
- Analyst Count
- RPRX 4
- JOBY 6
- Target Price
- RPRX $44.50
- JOBY $10.50
- AVG Volume (30 Days)
- RPRX 5.2M
- JOBY 43.3M
- Earning Date
- RPRX 11-05-2025
- JOBY 11-05-2025
- Dividend Yield
- RPRX 2.44%
- JOBY N/A
- EPS Growth
- RPRX 54.86
- JOBY N/A
- EPS
- RPRX 2.32
- JOBY N/A
- Revenue
- RPRX $2,305,243,000.00
- JOBY $98,000.00
- Revenue This Year
- RPRX $35.14
- JOBY $4,202.94
- Revenue Next Year
- RPRX $1.24
- JOBY $817.70
- P/E Ratio
- RPRX $15.51
- JOBY N/A
- Revenue Growth
- RPRX 3.02
- JOBY N/A
- 52 Week Low
- RPRX $24.05
- JOBY $4.80
- 52 Week High
- RPRX $38.00
- JOBY $20.95
- Technical
- Relative Strength Index (RSI)
- RPRX 51.05
- JOBY 69.58
- Support Level
- RPRX $35.36
- JOBY $14.91
- Resistance Level
- RPRX $36.67
- JOBY $17.18
- Average True Range (ATR)
- RPRX 0.74
- JOBY 1.08
- MACD
- RPRX 0.08
- JOBY 0.54
- Stochastic Oscillator
- RPRX 68.36
- JOBY 87.48
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About JOBY Joby Aviation Inc.
Joby Aviation Inc is a transportation company developing an all-electric, vertical take-off and landing (eVTOL) air taxi for commercial passenger service. Its Joby eVTOL aircraft is designed to transport a pilot and up to four passengers or an expected payload of up to 1,000 pounds at speeds of up to 200 mph. The aircraft is optimized for urban routes, with a target range of up to 100 miles on a single charge. The company is also developing an app-based platform to build and operate an aerial ridesharing service powered by a network of eVTOL aircraft that it will manufacture and operate. It has one operating and reportable segment, namely flight services. Currently, the company generates all of its revenue from flight services provided to the Department of Defense in the United States.